3D models in the new era of immune oncology: focus on T cells, CAF and ECM

Immune checkpoint inhibitor therapy has changed clinical practice for patients with different cancers, since these agents have demonstrated a significant improvement of overall survival and are effective in many patients. However, an intrinsic or acquired resistance frequently occur and biomarkers p...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Modugno, Francesca, Colosi, Cristina, Trono, Paola, Antonacci, Giuseppe, Ruocco, Giancarlo, Nisticò, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429763/
https://www.ncbi.nlm.nih.gov/pubmed/30898166
http://dx.doi.org/10.1186/s13046-019-1086-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429763/
https://www.ncbi.nlm.nih.gov/pubmed/30898166
http://dx.doi.org/10.1186/s13046-019-1086-2

Ejemplares similares